Get vaccinated

Make an appointment with your healthcare provider

Vaccination with Menveo® starts with your healthcare provider. If you have an adolescent who is 11 to 18 years of age, now is a good time to ask about a meningococcal disease vaccination as recommended by the Centers for Disease Control and Prevention (CDC).1

Here are some helpful questions to ask

  • Was my child ever vaccinated for meningococcal disease?
  • Does my child need to be vaccinated again?
  • If my child wasn’t vaccinated, is there a reason why?
  • Are there any activities my child should avoid that spread this disease?
  • Why is vaccination effective in helping protect my child from meningococcal disease?
  • What are the possible side effects of vaccination?
  • Can my child be vaccinated now or should I make an appointment?

If you’d like to take these questions with you to your appointment, please print out Questions to Ask Your Healthcare Provider.

Indication

Menveo is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Menveo is approved for use in persons 2 to 55 years of age. Menveo does not prevent N. meningitidis serogroup B infections.

Important Safety Information

You should not receive Menveo if you have had a severe allergic reaction to any ingredient of the vaccine, or if you have had a severe allergic reaction to a vaccine containing similar components as Menveo.

Side effects to Menveo include pain at the injection site, headache, muscle pain, fatigue, nausea, and fainting. Sometimes fainting is accompanied by falling with injury. Other side effects may occur.

Following vaccination with another US-licensed meningococcal conjugate vaccine, an evaluation of postmarketing adverse events suggested a potential for increased risk of Guillain-Barré Syndrome (GBS). There is not enough information to evaluate if a risk of GBS exists following administration of Menveo.

Tell your doctor if you are pregnant or planning to get pregnant.

Vaccination with Menveo may not protect all individuals.

For more information about Menveo, talk to your health-care professional.

Menveo.com has been developed by Novartis Vaccines as part of the company’s commitment to individual and public health.

References

  1. Meningitis: Meningococcal vaccination. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/meningitis/vaccine-info.html. Accessed March 3, 2010.
  2. Strunk JA, Rocchiccioli JT. Meningococcal meningitis: an emerging infectious disease. J Community Health Nurs. 2010;27:51–58.

Menveo.com Exit Notice

You are now leaving the Menveo.com site and moving to an external website independently operated and not managed by Novartis Vaccines and Diagnostics Inc. Novartis assumes no responsibility for the site. If you do not wish to leave this site, click Cancel. Or, click OK to continue.

OKCancel